|
BioCommerce Week’s Index to the
Diversified Molecular Biology Tools Companies |
||||
|---|---|---|---|---|
| Company |
Ticker
|
Current Price
(March 8, 2005) |
Last Price
(March 1, 2005) |
% Change
|
| Agilent |
A
|
24.36
|
24.48
|
-0.49
|
|
Applied Biosystems
|
ABI
|
20.69
|
20.71
|
-0.10
|
| BD |
BDX
|
58.85
|
59.88
|
-1.72
|
| Beckman |
BEC
|
69.88
|
70.45
|
-0.81
|
| Bio-Rad |
BIO
|
48.51
|
49.60
|
-2.20
|
| Bruker |
BRKR
|
3.78
|
3.66
|
3.28
|
| GE |
GE
|
36.06
|
35.22
|
2.39
|
| Harvard Bio |
HBIO
|
4.43
|
4.22
|
4.98
|
| Invitrogen |
IVGN
|
71.66
|
70.56
|
1.56
|
| Molecular Devices |
MDCC
|
20.05
|
20.93
|
-4.20
|
| PerkinElmer |
PKI
|
23.01
|
22.20
|
3.65
|
| Sigma |
SIAL
|
63.79
|
62.37
|
2.28
|
| Stratagene |
STGN
|
7.39
|
6.82
|
8.36
|
| Thermo |
TMO
|
27.69
|
27.32
|
1.35
|
| Waters |
WAT
|
49.32
|
48.50
|
1.69
|
| Index Average |
|
35.30
|
35.13
|
0.48
|
Stratagene, Harvard Bio Lead as BCW Index Rises a Half Percent
Lifted by their fourth-quarter financial reports issued early this week, Stratagene and Harvard Bioscience shares closed up 8 percent and 5 percent, respectively, for the five-day period ending Tuesday.
The two companies were among nine of the 15 companies in the BioCommerce Week Index whose shares increased during the week.
PerkinElmer shares improved 3.7 percent for the week, followed by Bruker, which 3 percent after releasing its fourth-quarter financials and a raft of new products at last week's Pittcon (see article).
Molecular Devices led share-price losers with a 4 percent drop.
Overall, the Index finished up 0.5 percent, in positive territory for the second straight week with a close of $35.30. The Index has improved 13.5 percent since it debuted on Sept. 9, and reached a high-water mark of $36.10 on Feb. 8.
For the week, the BCW Index matched the Dow and the S&P 500, which were up 5 percent for the period, and outperformed the Nasdaq index, which closed level for the week, the Amex biotech index, which fell 3 percent, and the Amex pharma index, which was down over 0.5 percent.